Home > Insider Trading > Filing (0001209191-23-054904)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1907108	Lexeo Therapeutics Inc.	LXEO	()	4

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1253886	G Patrick Enright	C/O Longitude Capital 2740 Sand Hill Road, 2Nd Floor Menlo Park CA 94025	No	No	Yes	No
1431159	Juliet Bakker Tammenoms	C/O Longitude Capital 2740 Sand Hill Road, 2Nd Floor Menlo Park CA 94025	No	No	Yes	No
1787456	Longitude Venture Partners Iv, L.p.	2740 Sand Hill Road 2Nd Floor Menlo Park CA	No	No	Yes	No
1829169	Longitude Capital Partners Iv, Llc	2740 Sand Hill Road 2Nd Floor Menlo Park CA 94025	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2023-11-07	1,793,429	$0.00	1,793,429	No	4	C	Indirect	By Longitude Venture Partners IV, L.P.
Common Stock	Acquisiton	2023-11-07	319,126	$0.00	2,112,555	No	4	C	Indirect	By Longitude Venture Partners IV, L.P.
Common Stock	Acquisiton	2023-11-07	454,545	$11.00	2,567,100	No	4	P	Indirect	By Longitude Venture Partners IV, L.P.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	By Longitude Venture Partners IV, L.P.
No	4	C	Indirect	By Longitude Venture Partners IV, L.P.
No	4	P	Indirect	By Longitude Venture Partners IV, L.P.

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A convertible preferred stock	Disposition	2023-11-07	18,999,999	$0.00	1,793,429	$0.00
Common Stock	Series B convertible preferred stock	Disposition	2023-11-07	2,906,148	$0.00	319,126	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Indirect
0			No	4	C	Indirect

Footnotes

Upon the closing of the Issuer's initial public offering, each share of Series A convertible preferred stock automatically converted into shares of the Issuer's common stock on a one-for-10.594230 basis. The shares had no expiration date.
These shares are held by Longitude Venture Partners IV, L.P ("LVP IV"). Longitude Capital Partners IV, LLC ("LCP IV") is the general partner of LVP IV and may be deemed to have voting and dispositive power over the shares held by LVP IV. Mr. Enright and Ms. Tammenoms Bakker are managing members of LCP IV and may be deemed to share voting and dispositive power with respect to the shares held by LVP IV. Each of LCP IV, Mr. Enright and Ms. Tammenoms Bakker disclaims beneficial ownership of such shares and this report shall not be deemed an admission that any of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein.
Upon the closing of the Issuer's initial public offering, each share of Series B convertible preferred stock automatically converted into shares of the Issuer's common stock on a one-for-9.106601 basis, which reflects an anti-dilution adjustment to the conversion ratio pursuant to a provision of the Series B convertible preferred stock based on the pricing of the initial public offering (as described in the Reporting Person's Form 3). The shares had no expiration date.